Kaposi Sarcoma Early Detection, Diagnosis, and Staging

Learn about the signs and symptoms of Kaposi sarcoma (KS). Find out how it is tested for, diagnosed, and staged.

Can Kaposi sarcoma be found early?

Most cancers start in one place and then spread to other parts of the body. When these cancers are found early, treatment is more likely to be successful. Kaposi sarcoma (KS) is different because it tends to form in several areas at the same time.

KS often appears first as lesions on the skin, but even when only one skin lesion is visible, many people already have other areas of KS that are too small to be seen.

There are no recommended routine screening tests to look for KS in people who are not at increased risk of the disease.

Screening for Kaposi sarcoma if you have HIV

People with HIV, the virus that causes AIDS, are much more likely to develop KS. Many experts recommend people with HIV be examined regularly by health care providers experienced in recognizing KS and other diseases related to HIV infection and AIDS.

Symptoms of Kaposi sarcoma

Kaposi sarcoma (KS) usually starts as purple, red, or brown spots or lumps on your skin. These are called lesions. They are found most often on the legs or face, but they can show up anywhere on your skin. They can also appear on moist surfaces inside your body like your mouth and throat.

Sometimes KS lesions occur in organs inside the body. This can cause more serious symptoms. For example:

  • Lesions in your lungs can block airways and cause shortness of breath.
  • Lesions in your stomach or intestines might cause belly pain and diarrhea.

Some lesions inside the body might bleed, which can lead to symptoms like coughing up blood or having dark, tarry stools.

Tests to diagnose and stage Kaposi sarcoma

Kaposi sarcoma (KS) is often found when a person goes to the doctor because of signs or symptoms. Sometimes KS is found during a routine physical exam.

If your health care team suspects KS, they will need further tests to confirm the diagnosis. They may also do tests to figure out how much KS is in your body.

Medical history, physical exam, and lab tests

If your health care team suspects you might have KS, they will ask about your medical history to learn about your symptoms and possible risk factors, especially if you have a weakened immune system.

As part of the physical exam, the health care team will likely:

  • Examine your skin and the inside of your mouth to look for KS lesions.
  • Feel for enlarged lymph nodes on the sides of your neck, under your arms, and in your groin area.
  • Check your rectum with a lubricated, gloved finger because KS lesions sometimes develop inside the rectum.

The health care team may also check your stool for occult (unseen) blood because KS in the digestive tract can cause bleeding.

They might also order blood tests. For example:

  • To check your blood cell counts and blood chemistry levels
  • To test for HIV if you aren’t known to have it and haven’t been tested recently

Biopsy

To be sure that a lesion is KS, your health care team will take a sample of tissue from the lesion and send it to a lab to be checked. This is called a biopsy.

For skin lesions, a doctor usually does a punch biopsy, which removes a tiny round piece of tissue. Some lesions might be removed with a scalpel instead. If all of the lesion is removed, this is called an excisional biopsy. If only part is removed, it is called an incisional biopsy.

Skin biopsies can often be done with just local anesthesia (numbing medicine).

Lesions in your lungs, intestines, or other areas can be biopsied during procedures such as bronchoscopy or endoscopy, which are described below. Biopsy of lesions in these areas can sometimes cause serious bleeding, so it isn’t often done in people already known to have KS.

KS can sometimes affect other organs, such as your liver, spleen, heart, or bone marrow. These organs often don’t need to be biopsied if KS has already been confirmed with biopsies of other tissues.

All biopsy samples are sent to a lab, where a specially trained doctor called a pathologist looks at them under a microscope. They may also do other tests to find out if the samples contain KS cells.

Imaging tests

Imaging tests create pictures of the inside of your body. You might not need imaging tests, but they can be helpful in some situations.

You might have a chest x-ray to see if KS is in your lungs.

These tests create more detailed pictures of the inside of your body. A CT scan creates images using x-rays. An MRI does this with strong magnets.

These tests are typically only done if there is a reason to suspect KS might be in the lungs or digestive tract. You might get a CT scan or MRI if:

  • A chest x-ray shows something abnormal.
  • You have lung symptoms, such as shortness of breath or coughing up blood.
  • You have digestive symptoms, such as belly pain or diarrhea.
  • A test shows blood in your stool.

Bronchoscopy

Bronchoscopy is a test that lets the doctor look into your windpipe (trachea) and the larger airways of your lungs. It is often done if you’re having problems, such as shortness of breath or coughing up blood, or if a chest x-ray or CT scan shows something abnormal. Any of these could mean KS is in your lungs.

Before a bronchoscopy, you are usually given medicine through a vein (IV) to make you feel relaxed. Less often, you might be asleep for the test (under general anesthesia).

The doctor inserts a thin, flexible, lighted tube with a small video camera on the end through your mouth, down your windpipe, and into your lungs. This instrument is called a bronchoscope.

If the doctor sees an abnormal area that might be KS, it can be biopsied through the bronchoscope.

Gastrointestinal (GI) endoscopy

For this type of test, a thin, flexible, lighted tube with a small video camera on the end is put into your body through your mouth or rectum to look at parts of your gastrointestinal (GI) tract. This instrument is called an endoscope.

Your doctor might do one or more of the following tests if they suspect KS is in your stomach or intestines and causing problems.

Upper endoscopy, also called esophagogastroduodenoscopy or EGD, is used to look at the inner lining of your esophagus, stomach, and the first part of your small intestine.

For this procedure, you are typically given medicine through an intravenous (IV) line to make you feel relaxed. Less often, you might be asleep for the test (under general anesthesia).

The doctor guides the endoscope through your mouth and esophagus and into your stomach and small intestine. This lets them see things like ulcers, infections, and KS lesions.

If the doctor sees an abnormal area, they can use small surgical tools through the endoscope to biopsy it.

Colonoscopy is used to look inside your large intestine (colon and rectum).

Before this test can be done, your colon and rectum must be cleaned out to remove any stool. This often means drinking a large amount of a liquid laxative the night before and the morning of the procedure. A laxative is a medicine that quickly clears the stool out of your body.

Just before the procedure, you will get intravenous (IV) medicine to make you relaxed or even fall asleep (sedation).

The doctor inserts a colonoscope (a type of endoscope) through your rectum and into your colon. If they see any abnormal areas, those can be biopsied.

Double balloon enteroscopy is a way to look inside your small intestine. Most of the small intestine can't be viewed with an upper endoscopy because it is too long (about 20 feet) and has too many curves. This method gets around these problems by using a special endoscope made up of 2 tubes, one inside the other.

For this test, you will get intravenous (IV) medicine to make you relaxed (sedation) or general anesthesia to put you to sleep.

The endoscope is inserted through your mouth or rectum, depending on what part of your small intestine needs to be examined.

Once inside your small intestine, the inner tube and video camera are advanced about a foot as the doctor looks at the lining of your intestine. A balloon is inflated to anchor the inner tube in place. The outer tube is then pushed forward and anchored in place with a second balloon.

This process is repeated over and over, letting the doctor see your intestine one foot at a time. The doctor can take a biopsy if they see something abnormal.

The procedure can take hours. It is more involved than capsule endoscopy (described below), but it has the advantage of letting the doctor biopsy any lesions that are seen.

Capsule endoscopy is another way to look at the small intestine. Despite the name, it’s not truly a type of endoscopy since it doesn’t use an endoscope. Instead, you swallow a capsule about the size of a large vitamin pill that has a light along with a very small camera.

You will probably be told not to eat or drink for about 12 hours before the test.

The capsule goes through your small intestine in about 8 hours. During this time, it takes thousands of pictures and sends them to a device you wear around your waist while going about your normal daily activities. The images are downloaded onto a computer where the doctor looks at them as a video.

The capsule passes out of your body through your stool during a normal bowel movement.

This test can often show abnormal areas in the small intestine, and it is easier to have than a double balloon enteroscopy. But one disadvantage is that the doctor can’t biopsy any abnormal areas during the test.

Kaposi sarcoma stages

If you are diagnosed with Kaposi sarcoma (KS), your cancer care team will try to figure out how much cancer is in your body (the extent) and how quickly it is likely to progress. This might affect your treatment options.

Is staging done for KS?

For most types of cancer, the extent of cancer in a person’s body is described in a standard way using a staging system. This is usually based on the size of the primary tumor (the first one to develop) and how far the cancer has spread from there.

There is no official system for staging all forms of Kaposi sarcoma although there is a staging system for HIV-related KS.

Still, no matter what type of KS you have, your cancer care team will want to know the extent of your disease.

Staging for HIV-related KS: The AIDS Clinical Trial Group system

The staging system for HIV-related KS, the most common type in the United States, is based on different factors than staging systems for most other cancers.

The outlook for people with HIV-related KS is influenced not only by how far the KS has spread but also by other factors, such as how much the immune system is damaged and the presence of AIDS-related infections.

The AIDS Clinical Trials Group (ACTG) system considers 3 factors:

  • The extent of the tumor (T)
  • The status of the immune system (I), as measured by the number of CD4 cells (a specific type of immune cell) in the blood
  • The extent of systemic illness (S) within the body (how sick the person is from the cancer or the HIV)

Since antiretroviral therapy (ART) became available to treat HIV, the immune status (I) has become less important.

Under each major heading, there are 2 subgroups:

  • 0 (good risk)
  • 1 (poor risk)

T0 (good risk): Localized tumor

KS is only in the skin and/or the lymph nodes (bean-sized collections of immune cells throughout the body), and/or there is only a small amount of disease on the palate (roof of the mouth). The KS lesions in the mouth are flat rather than raised.

T1 (poor risk): KS lesions are more widespread. One or more of the following is present:

  • Edema (swelling) or ulceration (breaks in the skin) due to the tumor
  • Extensive oral KS: Lesions are nodular (round lumps) and/or in areas of the mouth besides the palate (roof of the mouth)
  • KS lesions are in other organs (such as the lungs, stomach, intestines, liver, etc.)

The immune status is assessed using a blood test known as the CD4 count, which measures the number of white blood cells called helper T cells.

I0 (good risk): CD4 cell count is 150 or more cells per cubic millimeter (mm3).

I1 (poor risk): CD4 cell count is lower than 150 cells per mm3.

S0 (good risk): No systemic illness present; all of the following are true:

  • No history of opportunistic infections (infections that rarely cause problems in healthy people but affect people with suppressed immune systems) or thrush (a fungal infection in the mouth).
  • No B symptoms lasting more than 2 weeks. B symptoms include unexplained fever, night sweats severe enough to soak the bed clothes, weight loss of more than 10% without dieting, and diarrhea.
  • Karnofsky performance status (KPS) score of 70 or higher. This means you are up and about most of the time and able to take care of yourself.

S1 (poor risk): Systemic illness present; one or more of the following is true:

  • History of opportunistic infections or thrush
  • One or more B symptoms are present
  • KPS score is under 70
  • Other HIV-related illness is present, such as neurological (nervous system) disease or lymphoma

Overall, people with more good risk (0) categories tend to do better than people with more poor risk (1) categories.

Questions to ask if you have Kaposi sarcoma

It’s important to have frank, open discussions with your cancer care team. They want to answer all your questions so you can make informed treatment and life decisions. Consider asking these questions:

For any type of KS:

  • Is the KS in places other than my skin, such as my lymph nodes or other organs?
  • Do I have any other conditions caused by KSHV/HHV8?
  • Will I need other tests before we can decide on treatment?
  • Do I need to see any other doctors or health professionals?
  • Based on what you’ve learned about my cancer, what is my prognosis (outlook)?
  • If I’m concerned about the costs and insurance coverage for my diagnosis and treatment, who can help me?

For AIDS-related KS:

  • What is my CD4 count, and should I be doing anything to try to increase it?
  • Is my viral load controlled?
  • Are there infections or any other problems contributing to my condition?

side by side logos for American Cancer Society and American Society of Clinical Oncology

Developed by the American Cancer Society medical and editorial content team with medical review and contribution by the American Society of Clinical Oncology (ASCO).

Anampa J, Barta SK, Haigentz M, Sparano JA. Ch. 62: Human Immunodeficiency Virus (HIV) Infection and Cancer. In: Niederhuber JE, Armitage JO, Kastan MB, Tepper JE, eds. Abeloff’s Clinical Oncology. 6th ed. Philadelphia, PA: Elsevier; 2020.

Bettuzzi T, Lebbe C, Grolleau C. Modern approach to manage patients with Kaposi sarcoma. J Med Virol. 2025 Mar;97(3):e70294.

Groopman JE. AIDS-related Kaposi sarcoma: Clinical manifestations and diagnosis. UpToDate. 2025. Accessed at https://www.uptodate.com/contents/aids-related-kaposi-sarcoma-clinical-manifestations-and-diagnosis on October 1, 2025.

Krown SE, Singh JC. Classic Kaposi sarcoma: Clinical features, staging, diagnosis, and treatment. UpToDate. 2025. Accessed at https://www.uptodate.com/contents/classic-kaposi-sarcoma-clinical-features-staging-diagnosis-and-treatment on October 1, 2025.

Krown SE, Testa MA, Huang J. AIDS-related Kaposi’s sarcoma: Prospective validation of the AIDS Clinical Trials Group staging classification. AIDS Clinical Trials Group Oncology Committee. J Clin Oncol. 1997;15:3085−3092.

National Cancer Institute. Kaposi Sarcoma Treatment (PDQ®)–Health Professional Version. 2025. Accessed at https://www.cancer.gov/types/soft-tissue-sarcoma/hp/kaposi-treatment-pdq on October 1, 2025.

National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines): Kaposi Sarcoma. Version 2.2026. Accessed at www.nccn.org on September 19, 2025.

Ramaswami R, Lurain K, Yarchoan R. Oncologic treatment of HIV-associated Kaposi sarcoma 40 years on. J Clin Oncol. 2022;40(3):294-306.

Robles EP et al. Role of double-balloon enteroscopy in malignant small bowel tumors. World J Gastrointest Endosc. 2015; 7(6): 652–658.

Last Revised: December 5, 2025

American Cancer Society Emails

Sign up to stay up-to-date with news, valuable information, and ways to get involved with the American Cancer Society.